Xoft Electronic Brachytherapy Clinical Protocol For The Primary Treatment Of Non-Melanoma Skin Cancer
The objective of this study is to record local recurrence in patients treated for
nonmelanoma (basal cell and squamous cell carcinomas) skin cancer using the Xoft Axxent
Electronic Brachytherapy System. Additional objectives include evaluate the cosmetic
outcomes in patients treated for nonmelanoma skin cancer using the Xoft Axxent Electronic
Brachytherapy System and record the occurrence of radiation therapy related skin toxicities
in patients treated for nonmelanoma skin cancer using the Xoft Axxent Electronic
Brachytherapy System.
Observational
Observational Model: Cohort, Time Perspective: Prospective
Local recurrence of NMSC
at six (6) months, one (1) year, two (2) years, three (3) years, four (4) years, and five (5) years.
No
Ajay Bhatnagar, MD, MBA
Principal Investigator
Cancer Treatment Services-AZ
United States: Institutional Review Board
CTPR-0002
NCT01016899
July 2009
February 2016
Name | Location |
---|---|
Beth Israel Medical Center | New York, New York 10003 |
DCH Cancer Center | Tuscaloosa, Alabama 35401 |
Cancer Treatment Services - AZ | Casa Grande, Arizona 85222 |
Southwest Oncology Centers | Scottsdale, Arizona 85251 |
Diablo Valley Oncology and Hematology Medical Group | Pleasant Hill, California 94523 |
Parkridge Medical Center - Sara Cannon Cancer Center | Chattanooga, Tennessee 37404 |